Prefabricated Viral Vector Modular BSL-2LS cGMP Facility Designed, Built, Installed and Commissioned In 13 Months

At a critical juncture in its business development, German-based CDMO Vibalogics approached Germfree for assistance in expanding its footprint in the U.S. market for viral vectors. Vibalogics required a facility that could support three processing lines, each with a capacity of up to 2 x 2,000 liters, and include fill-finish capabilities.

Germfree was selected to design and construct a modular BSL-2LS cGMP facility that would meet these requirements while maintaining unidirectional process flow and robust engineering controls. The company's innovative solution involved designing and manufacturing a modular BSL-2LS cGMP facility composed of nine prefabricated modules. Continue reading to learn more about this facility and the outcomes of its implementation.